LIMINATUS PHARMA, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | — | $-15.8M | — |
| FY2024 | — | $-19.3M | — |
| FY2025 | — | $-9.8M | — |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | — | $-15.8M | — |
| FY2024 | — | $-19.3M | — |
| FY2025 | — | $-9.8M | — |